Clinical Trial Update: Bendamustine With Irinotecan Followed by Etoposide/Carboplatin for Patients With Extensive Stage Small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 trial evaluated bendamustine with irinotecan followed by etoposide/carboplatin in extensive-stage small cell lung cancer; results were pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer
• Small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Camptosar (irinotecan)
• Treanda (Bendamustine)
• VePesid (etoposide)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Small Cell Lung Cancer, Extensive Stage Lung Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-07-17